Healthcare -
Biotechnology - NASDAQ - FR
$ 1.69
1.2 %
$ 142 M
Market Cap
-3.93
P/E
IPHA - STOCK-BASED COMPENSATION
Stock-based Compensation IPHA - Innate Pharma S.A.
4.26 M
LAST VALUE
27.53%
2 YEAR CAGR
9.47%
5 YEAR CAGR
29.33%
10 YEAR CAGR